C-terminus of heat shock cognate 70 interacting protein increases following stroke and impairs survival against acute oxidative stress

Antioxidants and Redox Signaling

Volumn 14, Issue 10, 2011, Pages 1787-1801

  Stankowski, Jeannette N ^a,b   Zeiger, Stephanie L H ^b,c   Cohen, Evan L ^c   Defranco, Donald B ^d   Cai, Jiyang ^e   McLaughlin, Bethann ^b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C TERMINUS OF HEAT SHOCK COGNATE 70 INTERACTING PROTEIN; GLUCOSE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; OXYGEN; PROTEASOME; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; CARBOXY TERMINAL SEQUENCE; CELL FATE; CELL SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRAUMATIC BRAIN INJURY; UBIQUITINATION; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE; GLUTATHIONE DISULFIDE; IMMUNOBLOTTING; MICE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STROKE; UBIQUITIN-PROTEIN LIGASES;

EID: 79954608351     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3300     Document Type: Article

References (52)

1. Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, and Reynolds IJ. Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 75: 1878-1888, 2000.
2. Anderson LG, Meeker RB, Poulton WE, and Huang DY. Brain distribution of carboxy terminus of Hsc70-interacting protein (CHIP) and its nuclear translocation in cultured cortical neurons following heat stress or oxygen-glucose deprivation. Cell Stress Chaperones 15: 487-495, 2009.
3. Arndt V, Rogon C, and Hö hfeld J. To be, or not to be-molecular chaperones in protein degradation. Cell Mol Life Sci 64: 2525-2541, 2007. (Pubitemid 350035611)
4. Beere HM and Green DR. Stress management-heat shock protein-70 and the regulation of apoptosis. Trends Cell Biol 11: 6-10, 2001. (Pubitemid 32056181)
5. Berke SJS and Paulson HL. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr Opin Genet Dev 13: 253-261, 2003. (Pubitemid 36645088)
6. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21: 2-14, 2001. (Pubitemid 32036708)
7. Chen Y, Stevens B, Chang J, Milbrandt J, Barres BA, and Hell JW. NS21: re-defined and modified supplement B27 for neuronal cultures. J Neurosci Methods 171: 239-247, 2008.
8. ChoiDW. Excitotoxic cell death.JNeurobiol 23: 1261-1276, 1992.
9. Coux O, Tanaka K, and Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65: 801-847, 1996. (Pubitemid 26255262)
10. Cyr DM, Hohfeld J, and Patterson C. Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci 27: 368-375, 2002. (Pubitemid 34756520)
11. Dai Q, Zhang C, Wu Y, McDonough H, Whaley RA, Godfrey V, Li HH, Madamanchi N, Xu W, Neckers L, Cyr D, and Patterson C. CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J 22: 5446-5458, 2003. (Pubitemid 37279954)
12. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, and Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 23-38, 2003. (Pubitemid 36187411)
13. Davis JB and Maher P. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res 652: 169-173, 1994. (Pubitemid 24222914)
14. Dhodda VK, Sailor KA, Bowen KK, and Vemuganti R. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 89: 73-89, 2004. (Pubitemid 38420676)
15. Dickey CA, Patterson C, Dickson D, and Petrucelli L. Brain CHIP: removing the culprits in neurodegenerative disease. Trends Mol Med 13: 32-38, 2007. (Pubitemid 46027726)
16. Dirnagl U, Becker K, and Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8: 398-412, 2009.
17. Du S, McLaughlin B, Pal S, and Aizenman E. In vitro neurotoxicity of methylisothiazolinone, a commonly used industrial and household biocide, proceeds via a zinc and extracellular signal-regulated kinase mitogen-activated protein kinase-dependent pathway. J Neurosci 22: 7408-7416, 2002. (Pubitemid 35386340)
18. Giffard RG, Xu L, Zhao H, Carrico W, Ouyang Y, Qiao Y, Sapolsky R, Steinberg G, Hu B, and Yenari MA. Chaperones, protein aggregation, and brain protection from hypoxic= ischemic injury. J Exp Biol 207(Pt 18): 3213-3220, 2004. (Pubitemid 39275295)
19. Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55: 363-389, 2008.
20. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899, 2003. (Pubitemid 38056882)
21. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, Parada LF, Dawson TM, and Dawson VL. Requirement for nitric oxide activation of p21(ras)=extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA 97: 436-441, 2000. (Pubitemid 30055849)
22. Hohfeld J, Cyr DM, and Patterson C. From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep 10: 885-890, 2001. (Pubitemid 33040574)
23. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Nakayama K-I, and Takahashi R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 10: 55-67, 2002. (Pubitemid 34876562)
24. Keller JN, Huang FF, Zhu H, Yu J, Ho YS, and Kindy MS. Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab 20: 1467-1473, 2000.
25. Kiang JG and Tsokos GC. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 80: 183-201, 1998. (Pubitemid 28498227)
26. Labiche LA and Grotta JC. Clinical trials for cytoprotection in stroke. NeuroRx 1: 46-70, 2004. (Pubitemid 46591882)
27. Legos JJ, McLaughlin B, Skaper SD, Strijbos PJLM, Parsons AA, Aizenman E, Herin GA, Barone FC, and Erhardt JA. The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. Eur J Pharmacol 447: 37-42, 2002. (Pubitemid 34775218)
28. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568, 1999. (Pubitemid 29473320)
29. Luo Y and DeFranco DB. Opposing roles for ERK1=2 in neuronal oxidative toxicity: distinct mechanism of ERK1=2 action at early versus late phases of oxidative stress. J Biol Chem 281: 16436-16442, 2006.
30. Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res Rev 4: 288-314, 2005. (Pubitemid 41114862)
31. Maria JC, Rosa MS, José AR-N, Ana G, Juan P, Jose GC, Justo Garća De Y, and Maria AM. Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis. J Neurochem 110: 1523-1537, 2009.
32. McLaughlin BA, Hartnett KA, Erhardt JA, Legos JJ, White RF, Barone FC, and Aizenman E. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci USA 100: 715-720, 2003. (Pubitemid 36126118)
33. McLaughlin BA, Pal S, Tran MP, Parsons AA, Barone FC, Erhardt JA, and Aizenman E. p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J Neurosci 21: 3303-3311, 2001. (Pubitemid 32422795)
34. McLaughlin BA, Nelson D, Erecinska M, and Chesselet MF. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J Neurochem 70: 2406-2415, 1998. (Pubitemid 28252366)
35. McLaughlin BA, Nelson D, Silver IA, Erecinska M, and Chesselet M-F. Methylmalonate toxicity in primary neuronal cultures. Neuroscience 86: 279-290, 1998. (Pubitemid 28270873)
36. McNamara D and Dingledine R. Dual effect of glycine on NMDA-induced neurotoxicity in rat cortical cultures. J Neurosci 10: 3970-3976, 1990.
37. Mehta SL, Manhas N, and Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54: 34-66, 2007. (Pubitemid 46498164)
38. Musiek ES, Breeding RS, Milne GL, Zanoni G, Morrow JD, and McLaughlin B. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J Neurochem 97: 1301-1313, 2006. (Pubitemid 43725570)
39. Petrucelli L and Dawson TM. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Ann Med 36: 315-320, 2004. (Pubitemid 38789286)
40. Pratt WB, Morishima Y, Peng H-M, and Osawa Y. Proposal for a role of the Hsp90=Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage. Exp Biol Med 235: 278-289, 2010.
41. Qian S-B, McDonough H, Boellmann F, Cyr DM, and Patterson C. CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature 440: 551, 2006.
42. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y, and the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 117: e25-e146, 2008.
43. Rosser MFN, Washburn E, Muchowski PJ, Patterson C, and Cyr DM. Chaperone Functions of the E3 Ubiquitin Ligase CHIP. J Biol Chem 282: 22267-22277, 2007. (Pubitemid 47267320)
44. Sahara N, Murayama M, Mizoroki T, Urushitani M, Imai Y, Takahashi R, Murata S, Tanaka K, and Takashima A. In vivo evidence of CHIP up-regulation attenuating tau aggregation. J Neurochem 94: 1254-1263, 2005. (Pubitemid 41232581)
45. Sharp FR, Massa SM, and Swanson RA. Heat-shock protein protection. Trends Neurosci 22: 97-99, 1999. (Pubitemid 29151800)
46. Van Leyen K, Siddiq A, Ratan RR, and Lo EH. Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity. J Neurochem 92: 824-830, 2005. (Pubitemid 40229554)
47. Von Engelhardt J, Coserea I, Pawlak V, Fuchs EC, Köhr G, Seeburg PH, and Monyer H. Excitotoxicity in vitro by NR2A-and NR2B-containing NMDA receptors. Neuropharmacology 53: 10-17, 2007. (Pubitemid 47125951)
48. Wang L, Chen Y, Sternberg P, and Cai J. Essential roles of the PI3 kinase=Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Invest Ophthalmol Vis Sci 49: 1671-1678, 2008.
49. Wang X and Defranco DB. Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase. Mol Endocrinol 19: 1474-1482, 2005. (Pubitemid 41002979)
50. Yenari MA. Heat shock proteins and neuroprotection. Adv Exp Med Biol 513: 281-299, 2002. (Pubitemid 36332411)
51. Zhang C, Xu Z, He X-R, Michael LH, and Patterson C. CHIP, a cochaperone=ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 288: H2836-H2842, 2005. (Pubitemid 40720665)
52. Zhang F, Liu CL, and Hu BR. Irreversible aggregation of protein synthesis machinery after focal brain ischemia. J Neurochem 98: 102-112, 2006. (Pubitemid 43882936)